AstraZeneca is withdrawing its COVID-19 vaccine from the market because of low demand, the drugmaker said Wednesday. The shot ...

Novavax stock surges after the vaccine maker signs a $1.2 billion licensing deal with France’s Sanofi, guidance from Akamai ...

Novavax stock skyrocketed Friday, up 120% on the news that French drug and vaccine giant Sanofi is investing $1.2 billion in ...

A poorly framed article on people who believe that COVID-19 vaccines injured them is being trumpeted by antivaxxerst. Where ...

All vaccines have at least occasional side effects. But people who say they were injured by COVID vaccines believe their cases have been ignored.

Moderna beat Wall Street's first-quarter expectations Thursday. The news could bolster Moderna stock, which is approaching ...

28, Pfizer provided the FDA with safety and efficacy data ... the world have yet to get a single shot. No. Lots of vaccines either require booster doses or, like the flu shot, are given annually.

AstraZeneca has confirmed that it is withdrawing its COVID vaccine, due to what it says is a "surplus of available updated ...

Pfizer and Moderna's vaccines for children as young as 6 months old could be available next week after an FDA advisory panel recommended them on Wednesday.

After that, the FDA approved the company’s updated COVID booster shot, making it available alongside shots from Moderna and ...

The change was mainly due to recognizing lower cost of sales from BioNTech’s decreased COVID-19 vaccine sales, which included the share of gross profit that BioNTech owes its collaboration partner ...

All vaccines have at least occasional side effects. But people who say they were injured by Covid vaccines believe their ...